Literature DB >> 15541901

Gabaergic neurons with alpha2-adrenergic receptors in basal forebrain and preoptic area express c-Fos during sleep.

M Modirrousta1, L Mainville, B E Jones.   

Abstract

The basal forebrain (BF) contains cholinergic neurons that stimulate cortical activation during waking. In addition, both the BF and adjacent preoptic area (POA) contain neurons that promote sleep. We examined c-Fos expression in cholinergic and GABAergic neurons in the BF and POA to determine whether they are differentially active following sleep deprivation versus recovery and whether the GABAergic neurons are active during sleep. Whereas the numbers of c-Fos+ cells and proportions of c-Fos+ cells that were cholinergic were decreased, the proportions that were GABAergic were increased following sleep recovery across BF and POA nuclei. Moreover, the sleep-active GABAergic neurons were immunostained for alpha2A-adrenergic receptors. We conclude that GABAergic neurons that commonly bear alpha2-adrenergic receptors comprise sleep-active cells of the BF and POA. These GABAergic cells would be inhibited by noradrenaline (NA) released from locus coeruleus neurons during waking; they would be disinhibited through diminished NA release during drowsiness and thus become active to promote sleep by inhibiting in turn wake-promoting neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541901     DOI: 10.1016/j.neuroscience.2004.07.028

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  40 in total

1.  Sleep deprivation triggers inducible nitric oxide-dependent nitric oxide production in wake-active basal forebrain neurons.

Authors:  Anna V Kalinchuk; Robert W McCarley; Tarja Porkka-Heiskanen; Radhika Basheer
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

Review 2.  Hypothalamic control of sleep in aging.

Authors:  Asya Rolls
Journal:  Neuromolecular Med       Date:  2012-03-09       Impact factor: 3.843

3.  Thalamic Cav3.1 T-type Ca2+ channel plays a crucial role in stabilizing sleep.

Authors:  Matthew P Anderson; Takatoshi Mochizuki; Jinghui Xie; Walter Fischler; Jules P Manger; Edmund M Talley; Thomas E Scammell; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-26       Impact factor: 11.205

4.  Kv2.2: a novel molecular target to study the role of basal forebrain GABAergic neurons in the sleep-wake cycle.

Authors:  Tracey O Hermanstyne; Kalpana Subedi; Wei Wei Le; Gloria E Hoffman; Andrea L Meredith; Jessica A Mong; Hiroaki Misonou
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

5.  A role for the preoptic sleep-promoting system in absence epilepsy.

Authors:  N Suntsova; S Kumar; R Guzman-Marin; M N Alam; R Szymusiak; D McGinty
Journal:  Neurobiol Dis       Date:  2009-07-23       Impact factor: 5.996

6.  Suprachiasmatic modulation of noradrenaline release in the ventrolateral preoptic nucleus.

Authors:  Benoît Saint-Mleux; Laurence Bayer; Emmanuel Eggermann; Barbara E Jones; Michel Mühlethaler; Mauro Serafin
Journal:  J Neurosci       Date:  2007-06-13       Impact factor: 6.167

Review 7.  Principal cell types of sleep-wake regulatory circuits.

Authors:  Barbara E Jones
Journal:  Curr Opin Neurobiol       Date:  2017-04-19       Impact factor: 6.627

8.  Discharge profiles of identified GABAergic in comparison to cholinergic and putative glutamatergic basal forebrain neurons across the sleep-wake cycle.

Authors:  Oum Kaltoum Hassani; Maan Gee Lee; Pablo Henny; Barbara E Jones
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

9.  Why we sleep: the temporal organization of recovery.

Authors:  Emmanuel Mignot
Journal:  PLoS Biol       Date:  2008-04-29       Impact factor: 8.029

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.